Search Results - "GERMA, Josep Ramon"

Refine Results
  1. 1

    CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD) by Oaknin, Ana, Barretina, Pilar, Pérez, Xavier, Jimenez, Laura, Velasco, Montserrat, Alsina, Maria, Brunet, Joan, Germà, Josep Ramon, Beltran, Miguel

    “…: In recurrent ovarian cancer, CA-125 could be the only objective response criteria. This study analyzes response patterns regarding CA-125 in responders…”
    Get more information
    Journal Article
  2. 2
  3. 3

    The impact of KRAS mutations on VEGF-A production and tumour vascular network by Figueras, Agnès, Arbos, Maria Antonia, Quiles, Maria Teresa, Viñals, Francesc, Germà, Josep Ramón, Capellà, Gabriel

    Published in BMC cancer (18-03-2013)
    “…The malignant potential of tumour cells may be influenced by the molecular nature of KRAS mutations being codon 13 mutations less aggressive than codon 12…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Impact on budget of new drugs for colorectal cancer treatment by Corral, M Julieta, Clopès, Ana, Navarro, Matilde, Germà, Josep Ramon, Borràs, Josep Maria

    Published in Medicina clínica (23-06-2007)
    “…To assess the impact on the medicines budget of the introduction of new treatments in colorectal cancer, as monoclonal antibodies cetuximab and bevacizumab and…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer by Urruticoechea, Ander, Aguilar, Helena, Solé, Xavier, Capellà, Gabriel, Martin, Lesley-Ann, Dowsett, Mitch, Germà-Lluch, Josep Ramon

    Published in Breast cancer research and treatment (01-06-2008)
    “…Introduction Changes in breast cancer cell biology following hormonal treatment have been claimed as promising predictor markers of clinical benefit even…”
    Get full text
    Journal Article
  10. 10

    Common genetic evolutionary pathways in familial adenomatous polyposis tumors by TARAFA, Gemma, PRAT, Esther, GERMA, Josep-Ramon, MIRO, Rosa, PEINADO, Miguel Angel, CAPELLA, Gabriel, RISQUES, Rosa-Ana, GONZALEZ, Sara, CAMPS, Jordi, GRAU, Monica, GUINO, Elisabeth, MORENO, Victor, ESTELLER, Manel, HERMAN, James G

    Published in Cancer research (Chicago, Ill.) (15-09-2003)
    “…Cancer cells progress through the accumulation of genetic alterations. Familial adenomatous polyposis (FAP) tumors provide an excellent model to unravel the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Molecular bases of platinum-resistance in testicular cancer by Germà-Lluch, Josep Ramon, Piulats, Josep Maria

    Published in Archivos españoles de urología (01-06-2013)
    “…Cisplatin has been the cornerstone of germ cell testicular tumors therapy since its introduction more tan 30 years ago, and a basic part of the schemes given…”
    Get full text
    Journal Article
  14. 14

    Indium-111-Antimyosin Scintigraphy After Doxorubicin Therapy in Patients with Advanced Breast Cancer by Estorch, Montserrat, Carrio, Ignasi, Berna, Lluis, Martinez-Duncker, Carlos, Alonso, Carmen, Germa, Josep-Ramon, Ojeda, Belen

    Published in The Journal of nuclear medicine (1978) (01-12-1990)
    “…Indium-111-antimyosin (111In-antimyosin) scans were performed in 20 women with advanced breast cancer after 10 cycles of chemotherapy consisting of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands by González, Sara, Blanco, Ignacio, Campos, Olga, Julià, María, Reyes, José, Llompart, Alfred, Cabeza, Elena, Germà, Josep Ramon, Obrador, Antoni, Capellá, Gabriel

    Published in Cancer genetics and cytogenetics (01-04-2005)
    “…The incidence of familial adenomatous polyposis (FAP) is approximately 7.4 per 100,000 inhabitants. APC gene mutations have been found in 60–70% of all FAP…”
    Get full text
    Journal Article
  17. 17

    Radioimmune Imaging of Bone Marrow in Patients with Suspected Bone Metastases from Primary Breast Cancer by Duncker, Carlos M, Carrio, Ignasi, Berna, Lluis, Estorch, Montserrat, Alonso, Carmen, Ojeda, Belen, Blanco, Remei, Germa, Josep-Ramon, Ortega, Victoria

    Published in The Journal of nuclear medicine (1978) (01-09-1990)
    “…Radioimmune imaging of bone marrow was performed by technetium-99m- (99mTc) labeled antigranulocyte monoclonal antibody BW 250/183 (AGMoAb) scans in 32…”
    Get full text
    Journal Article
  18. 18

    Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma by García, Margarita, del Muro, Xavier García, Tres, Alejandro, Crespo, Carmen, Valladares, Manuel, López, Juan José, Rifà, Julio, Pérez, Xavier, Filipovich, Elena, Germà-Lluch, Josep Ramón

    Published in Melanoma research (01-08-2006)
    “…Temozolomide is a novel oral alkylating agent, active against metastatic melanoma. Combinations of chemotherapy and biological response modifiers have been…”
    Get full text
    Journal Article
  19. 19

    Evaluation of clinical research studies in a comprehensive cancer center by García, Margarita, Lluch, Josep Ramon Germà, Serra, Carles, Pérez, Xavier, Berenguer, Gema, Borràs, Josep Maria

    Published in Medicina clínica (21-02-2004)
    “…The number of clinical trials in cancer patients has experienced an important growth during last years. However, it is difficult to find data showing this…”
    Get more information
    Journal Article
  20. 20